169 related articles for article (PubMed ID: 17454603)
1. Angiogenesis in non-Hodgkin's lymphoma: clinico-pathological correlations and prognostic significance in specific subtypes.
Jørgensen JM; Sørensen FB; Bendix K; Nielsen JL; Olsen ML; Funder AM; d'Amore F
Leuk Lymphoma; 2007 Mar; 48(3):584-95. PubMed ID: 17454603
[TBL] [Abstract][Full Text] [Related]
2. Expression level, tissue distribution pattern, and prognostic impact of vascular endothelial growth factors VEGF and VEGF-C and their receptors Flt-1, KDR, and Flt-4 in different subtypes of non-Hodgkin lymphomas.
Jørgensen JM; Sørensen FB; Bendix K; Nielsen JL; Funder A; Karkkainen MJ; Tainola T; Sørensen AB; Pedersen FS; D'Amore F
Leuk Lymphoma; 2009 Oct; 50(10):1647-60. PubMed ID: 19701853
[TBL] [Abstract][Full Text] [Related]
3. Angiogenesis in nodal B cell lymphomas: a high throughput study.
Tzankov A; Heiss S; Ebner S; Sterlacci W; Schaefer G; Augustin F; Fiegl M; Dirnhofer S
J Clin Pathol; 2007 May; 60(5):476-82. PubMed ID: 16790692
[TBL] [Abstract][Full Text] [Related]
4. Magnitude of stromal hemangiogenesis correlates with histologic subtype of non-Hodgkin's lymphoma.
Ruan J; Hyjek E; Kermani P; Christos PJ; Hooper AT; Coleman M; Hempstead B; Leonard JP; Chadburn A; Rafii S
Clin Cancer Res; 2006 Oct; 12(19):5622-31. PubMed ID: 17020964
[TBL] [Abstract][Full Text] [Related]
5. Clinical Significance of VEGF-A and Microvessel Density in Diffuse Large B-Cell Lymphoma and Low-Grade Follicular Lymphoma.
Shahini L; Gašparov S; Petruševska G; Manxhuka Kerliu S; Veselaj F; Kurshumliu F; Kavaja F
Acta Clin Croat; 2017 Dec; 56(4):588-593. PubMed ID: 29590710
[TBL] [Abstract][Full Text] [Related]
6. Prognostic significance of EBV-LMP1 and VEGF-A expressions in non-Hodgkin's lymphomas.
Paydas S; Ergin M; Erdogan S; Seydaoglu G
Leuk Res; 2008 Sep; 32(9):1424-30. PubMed ID: 18282597
[TBL] [Abstract][Full Text] [Related]
7. [Clinical and pathological reassessment of 493 cases of non-Hodgkin's lymphomas according to current WHO classification of lymphoid neoplasms].
Xiao C; Su ZL; Wu QL; Gao HY; Fang JC; Xia ZJ; Guan ZZ
Zhonghua Bing Li Xue Za Zhi; 2005 Jan; 34(1):22-7. PubMed ID: 15796877
[TBL] [Abstract][Full Text] [Related]
8. The Role of Lymphocyte to Monocyte Ratio, Microvessel Density and HiGH CD44 Tumor Cell Expression in Non Hodgkin Lymphomas.
Jelicic J; Balint MT; Jovanovic MP; Boricic N; Micev M; Stojsic J; Antic D; Andjelic B; Bila J; Balint B; Pavlovic S; Mihaljevic B
Pathol Oncol Res; 2016 Jul; 22(3):567-77. PubMed ID: 26750138
[TBL] [Abstract][Full Text] [Related]
9. Expression of tenascin is related to histologic malignancy and angiogenesis in b-cell non-Hodgkin's lymphomas.
Vacca A; Ribatti D; Fanelli M; Costantino F; Nico B; Di Stefano R; Serio G; Dammacco F
Leuk Lymphoma; 1996 Aug; 22(5-6):473-81. PubMed ID: 8882961
[TBL] [Abstract][Full Text] [Related]
10. Prognostic significance of vascular endothelial growth factor, basic fibroblastic growth factor, and microvessel density and their relation to cell proliferation in B-cell non-Hodgkin's lymphoma.
Alshenawy HA
Ann Diagn Pathol; 2010 Oct; 14(5):321-7. PubMed ID: 20850693
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of rituximab plus chemotherapy in follicular lymphoma depends on Ki-67 expression.
Saito B; Shiozawa E; Yamochi-Onizuka T; Adachi D; Nakamaki T; Tomoyasu S; Omine M; Mitsuya T; Takimoto M; Ota H
Pathol Int; 2004 Sep; 54(9):667-74. PubMed ID: 15363034
[TBL] [Abstract][Full Text] [Related]
12. In situ follicular lymphoma associated with overt B- or T-cell lymphomas in the same lymph node.
Carbone A; Della Libera D; Zannier L; Selva A; Ceolin P; Gualeni A; Canal B; Gloghini A
Am J Hematol; 2011 Dec; 86(12):E66-70. PubMed ID: 21956856
[TBL] [Abstract][Full Text] [Related]
13. The importance of angiogenesis markers in the outcome of patients with diffuse large B cell lymphoma: a retrospective study of 97 patients.
Ganjoo KN; Moore AM; Orazi A; Sen JA; Johnson CS; An CS
J Cancer Res Clin Oncol; 2008 Mar; 134(3):381-7. PubMed ID: 17694324
[TBL] [Abstract][Full Text] [Related]
14. Intratumoral microvascular density in malignant lymphomas of B-cell origin.
Ridell B; Norrby K
APMIS; 2001 Jan; 109(1):66-72. PubMed ID: 11297195
[TBL] [Abstract][Full Text] [Related]
15. Microvessel density and expression of vascular endothelial growth factor and its receptors in diffuse large B-cell lymphoma subtypes.
Gratzinger D; Zhao S; Marinelli RJ; Kapp AV; Tibshirani RJ; Hammer AS; Hamilton-Dutoit S; Natkunam Y
Am J Pathol; 2007 Apr; 170(4):1362-9. PubMed ID: 17392174
[TBL] [Abstract][Full Text] [Related]
16. FilGAP, a Rac-specific Rho GTPase-activating protein, is a novel prognostic factor for follicular lymphoma.
Nishi T; Takahashi H; Hashimura M; Yoshida T; Ohta Y; Saegusa M
Cancer Med; 2015 Jun; 4(6):808-18. PubMed ID: 25641953
[TBL] [Abstract][Full Text] [Related]
17. Expression of Myc target gene mina53 in subtypes of human lymphoma.
Teye K; Arima N; Nakamura Y; Sakamoto K; Sueoka E; Kimura H; Tsuneoka M
Oncol Rep; 2007 Oct; 18(4):841-8. PubMed ID: 17786344
[TBL] [Abstract][Full Text] [Related]
18. Increased vascularization predicts favorable outcome in follicular lymphoma.
Koster A; van Krieken JH; Mackenzie MA; Schraders M; Borm GF; van der Laak JA; Leenders W; Hebeda K; Raemaekers JM
Clin Cancer Res; 2005 Jan; 11(1):154-61. PubMed ID: 15671540
[TBL] [Abstract][Full Text] [Related]
19. Differential expression of Toll-like receptors in follicular lymphoma, diffuse large B-cell lymphoma and peripheral T-cell lymphoma.
Smith TJ; Yamamoto K; Kurata M; Yukimori A; Suzuki S; Umeda S; Sugawara E; Kojima Y; Sawabe M; Nakagawa Y; Suzuki K; Crawley JT; Kitagawa M
Exp Mol Pathol; 2010 Dec; 89(3):284-90. PubMed ID: 20800061
[TBL] [Abstract][Full Text] [Related]
20. Prognostic significance of microvessel density and vascular endothelial growth factor (VEGF) expression in non-Hodgkin's lymphoma.
Hazar B; Paydas S; Zorludemir S; Sahin B; Tuncer I
Leuk Lymphoma; 2003 Dec; 44(12):2089-93. PubMed ID: 14959852
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
